Eczacibasi Pharmaceuticals Co.

Eczacibasi Pharmaceuticals comprises of three manufacturing and two marketing companies. It has a capacity of 200 million units. It is a certified institution in accordance with cGMP and cGLP. MHRA from UK, BfArM from Germany have reviewed and given their full approval to all of the plant’s production units. Eczacibasi Pharmaceuticals initiated sales to more than 20 countries across the world.

Activity:

- Contract Manufacturing
- Informatics
- Licensing & Business Development
- Manufacturing
- Regulatory Affairs & Legal Services
- Sales & Distribution
- Other Industry Services

Product / Technology type(s) covered:

- API / chemicals
- Bio
- Cosmoceuticals
- Curative
- Generics
- FP (finished products)
- OTC (over the counter drugs)
- Nutritionals / Vitamins
- Prescription drugs (Rx)
- Preventive

Therapeutic targets:

- Allergy
- Arthritis / Rheumato
- Asthma
- Cough / Cold
- Diabetes
- Gastrointestinal
- Infectious Diseases
- Men's Health
- Reproductive Health
- Urology
- Women's Health

Markets Covered

a. HeadQuarter: Turkey

b. Continent(s) active: Europe , Asia , Near/Middle East , Far East , Central/South America

c. Countries active: Germany, UK, Denmark, Spain, France and others

Corporate data:

Number of Employees: 1000

Turnover:

Amount:	Year:	Currency:
200M	2002	US Dollar

Year founded: 1952